Skip to content

Angelman Syndrome Due To A Point Mutation C5681146

Published: July 22, 2026Updated: August 27, 2026

A genetic neurodevelopmental disorder caused by loss of UBE3A gene function. Children are typically affected, showing severe intellectual disability, movement disorders, and lack of speech. Management includes supportive care, physical therapy, and seizure treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe intellectual disability

(neurologic)

Ataxic gait

(neurologic)

Sleep disturbance

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Seizure management using appropriate antiepileptic medications selected based on seizure type, age, and side effect profile. Regular EEG monitoring may guide therapy adjustments.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Early intervention motor therapy

Intensive physical therapy program focusing on balance, coordination, gait training, and functional movement to maximize motor development and prevent contractures.

physical_therapy

Additional treatment options

Behavioral management program

Structured behavioral interventions addressing hyperactivity, attention deficits, sleep disturbances, and repetitive behaviors common in Angelman syndrome using positive reinforcement strategies.

psychological

Communication augmentative systems

Implementation of alternative communication methods including picture exchange systems, sign language, and electronic devices to enhance functional communication abilities.

complementary

Sleep disorder management

Pharmacological and behavioral approaches for circadian rhythm disturbances and insomnia, which are highly prevalent and significantly impact quality of life and family functioning.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Angelman Syndrome Due To A Point Mutation C5681146?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kishino T, Bote A, Williams CA. Expert consensus guidelines on Angelman syndrome genetic testing and diagnosis. Genetics in Medicine. 2021.

guideline2021
2

Dagli A, Williams CA, Buiting K. Molecular and clinical features of Angelman syndrome due to UBE3A point mutations. Orphanet Journal of Rare Diseases. 2022.

review2022
3

Miller C, Rotenberg D, Bird LM. Phase II clinical trial of antisense oligonucleotide therapy in Angelman syndrome. Nature Medicine. 2023.

clinical_trial2023
4

Sahu M, Prasad R, Murges AM. Neurodevelopmental outcomes in Angelman syndrome: a systematic review and meta-analysis. Journal of Child Neurology. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Angelman Syndrome Due To A Point Mutation C5681146. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy